Viewing Study NCT01568892


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2025-12-28 @ 6:10 PM
Study NCT ID: NCT01568892
Status: COMPLETED
Last Update Posted: 2018-07-02
First Post: 2012-03-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Sponsor: ViiV Healthcare
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ART-experienced View
None GSK1349572 View
None Integrase inhibitor resistance View
None Dolutegravir View